EZH2 promotes proliferation and invasiveness of prostate cancer cells.

BRYANT, R J, CROSS, N A, EATON, C L, HAMDY, F C and CUNLIFFE, V T (2007). EZH2 promotes proliferation and invasiveness of prostate cancer cells. The Prostate, 67 (5), 547-556.

Full text not available from this repository.
Link to published version:: https://doi.org/10.1002/pros.20550
Related URLs:

    Abstract

    BACKGROUND : The transcriptional repressor EZH2 is implicated in control of cell proliferation in embryonic, immortalized and transformed cells. EZH2 expression in prostate cancer correlates with progression to hormone-refractory and metastatic disease, but it is unknown whether EZH2 plays a specific role in the acquisition of an advanced prostate cancer phenotype.

    METHODS : Using siRNA knockdown, we investigated the role of EZH2 in maintenance of prostate cancer cell proliferation and invasiveness. Using LNCaP cells with inducible EZH2 overexpression, we investigated whether EZH2 upregulation promotes an aggressive phenotype.

    RESULTS : Knockdown of endogenous EZH2 reduced proliferation of androgen-responsive and androgen-independent prostate cancer cells. EZH2 knockdown also inhibited prostate cancer cell invasion. However, overexpression of EZH2 in androgen-responsive cancer cells did not appreciably affect either proliferation or invasiveness.

    CONCLUSIONS : EZH2 promotes proliferation and invasion of prostate cancer cells, which can account for the correlation between EZH2 expression levels and an adverse prostate cancer prognosis.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.1002/pros.20550
    Page Range: 547-556
    Depositing User: Jamie Young
    Date Deposited: 01 Jun 2015 11:40
    Last Modified: 13 Jun 2017 13:29
    URI: http://shura.shu.ac.uk/id/eprint/9979

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics